Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00346905 · ClinicalTrials.gov registry record · NA
Endoscopic Implantation of Enteryx for the Treatment of GERD
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT00346905 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 16 participants.
The verdict
NCT00346905, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The study objective is to assess the long term safety and effectiveness of Enteryx device in commercial use. The long-term effects beyond one year of treatment with Enteryx have not been established.
Interventions
- DRUG Enteryx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2003-10 |
| Est. Completion | 2008-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00346905
The ClinicalTrials.gov registry entry for NCT00346905 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enteryx is the first listed.
NCT00346905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00346905 about?
NCT00346905 is a clinical study titled "Endoscopic Implantation of Enteryx for the Treatment of GERD". The study objective is to assess the long term safety and effectiveness of Enteryx device in commercial use. The long-term effects beyond one year of treatment with Enteryx have not been established.
What is the current status of trial NCT00346905?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2003-10. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00346905?
The interventions under investigation include: Enteryx (DRUG).
Who is sponsoring clinical trial NCT00346905?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.